Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

medRxiv(2020)10.1101/2020.12.09.20245175Source: DataRank Database

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 13.0. It has been cited 171 times, with 157 citing works in its 1-hop citation network.

N/A

13.0DataRank · unranked

Scored on demand from live citation data

Open Access171 citations · 157 citing works in its network

Download PDF

Cite:

Linked data & code

gen eudract refseq nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: greenTopics (16)IDs (PubMed, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 6%Citation Network 94%

Base Score Contribution

0.772

From this paper's citation signal

Citation Network Contribution

12.2

From 142 citing papers with measurable signal

Learn more about DataRank methodology →

Authors (52)

Alexander Muik ORCID,Isabel Vogler ORCID,Evelyna Derhovanessian,Lena M. Kranz ORCID,Mathias Vormehr ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W3113031614

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/12/11/2020.12.09.20245175.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.12.09.20245175

repositoryhttps://doi.org/10.1101/2020.12.09.20245175

Europe_PMChttps://europepmc.org/article/PPR/PPR252032

Fields of Study

SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesCOVID-19 Clinical Research Studies

Keywords

AntibodyVirologyMedicineVaccinationTiterCD8Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCoronavirus disease 2019 (COVID-19)Immune systemDiseaseInternal medicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being